Concepedia

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

Jean‐Marc Classe, Cécile Loaec, Pierre Gimbergues, S. Alran, C. Tunon de Lara, Pierre‐François Dupré, Roman Rouzier, C. Faure, N. Paillocher, M.-P. Chauvet,

Breast Cancer Research and Treatment · 2018 · 263 citations · 27 references

DOI

Concepts

References

27

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology · 2011 · 2.4K citations

, , +16

The Sentinel Node in Breast Cancer — A Multicenter Validation Study

David N. Krag, Donald L. Weaver, Takamaru Ashikaga et al. · New England Journal of Medicine · 1998 · 2K citations · Full text

, , +17

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

Robert E. Mansel, Lesley Fallowfield, Mark Kissin et al. · JNCI Journal of the National Cancer Institute · 2006 · 1.7K citations

, , +16

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer

Judy C. Boughey · JAMA · 2013 · 1.6K citations · Full text

, , +17

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

Thorsten Kuehn, Ingo Bauerfeind, Tanja Fehm et al. · The Lancet Oncology · 2013 · 1.5K citations

, , +17